Skip to main content

Table 1 Baseline characteristics of the patients

From: Albumin levels predict mortality in sepsis patients with acute kidney injury undergoing continuous renal replacement therapy: a secondary analysis based on a retrospective cohort study

ALB tertiles

TI group

(0.00–2.20 g/dl)

T2 group

(2.30–2.70 g/dl)

T3 group

(2.80–5.90 g/dl)

P value

N (794)

218

286

290

 

ALB

1.92 ± 0.32

2.50 ± 0.14

3.17 ± 0.39

< 0.001

Time to death = 28 days

28.00 (3.00–28.00)

28.00 (4.00–28.00)

28.00 (7.00–28.00)

0.024

Time to death = 90 days

3.00 (1.00–29.69)

5.80 (1.00–58.96)

14.40 (1.00–90.00)

< 0.001

Age (years)

65.00 ± 12.85

63.72 ± 14.49

62.49 ± 14.59

0.137

K (mmol/L)

4.76 ± 1.15

4.59 ± 0.99

4.77 ± 1.12

0.098

HCO3 (mmol/L)

15.71 ± 5.18

17.10 ± 5.67

17.73 ± 5.76

< 0.001

P (mg/dL)

5.53 ± 2.26

5.47 ± 2.15

5.90 ± 2.45

0.067

aCCI score

2.00 (1.00–5.00)

3.00 (2.00–5.00)

3.00 (1.25–4.00)

0.155

BMI (kg/m2)

23.36 ± 4.48

23.39 ± 4.34

23.89 ± 4.54

0.309

SBP (mmHg)

110.44 ± 20.62

112.21 ± 21.71

111.71 ± 20.50

0.632

DBP (mmHg)

61.00 ± 13.91

61.05 ± 14.70

60.28 ± 13.79

0.774

MAP (mmHg)

77.42 ± 14.02

77.76 ± 15.58

77.23 ± 14.62

0.909

WBC (uL)

10,690.00 (5130.00–18,960.00)

11,070.00 (6355.00–18,285.00)

12,060.00 (8170.00–18,740.00)

0.171

HGB (g/dL)

9.23 ± 2.06

9.73 ± 1.98

10.03 ± 2.37

< 0.001

BUN (mg/dL)

55.00 (36.00–78.00)

49.00 (35.00–74.00)

48.00 (34.00–71.00)

0.162

Cr (mg/dL)

2.26 (1.59–3.16)

2.42 (1.67–3.39)

2.34 (1.66–3.36)

0.358

CRP (mg/L)

89.60 (20.10–199.50)

73.25 (20.55–176.70)

46.90 (15.00–133.50)

0.011

GFR (ml/min/1.73 m2)

27.05 (18.27–39.55)

26.45 (17.62–38.98)

26.30 (16.17–38.60)

0.547

UO (mL)

25.00 (4.25–100.00)

30.00 (5.00–96.25)

40.00 (10.00–100.00)

0.139

APACHE-II score

28.37 ± 7.63

27.46 ± 7.64

26.60 ± 8.48

0.047

SOFA score

12.26 ± 3.38

12.16 ± 3.45

11.64 ± 3.73

0.09

CRRT dose (mL/kg)

36.99 ± 5.01

36.62 ± 4.85

36.57 ± 4.39

0.579

Sex

   

0.187

Male

132 (60.55%)

189 (66.08%)

171 (58.97%)

 

Female

86 (39.45%)

97 (33.92%)

119 (41.03%)

 

MV

   

0.049

No

36 (16.51%)

57 (19.93%)

73 (25.26%)

 

Yes

182 (83.49%)

229 (80.07%)

216 (74.74%)

 

Indications for CRRT

   

0.326

Volume overload

22 (10.09%)

35 (12.24%)

45 (15.52%)

 

metabolic acidosis

49 (22.48%)

73 (25.52%)

61 (21.03%)

 

hyperkalemia

14 (6.42%)

8 (2.80%)

17 (5.86%)

 

uremia

23 (10.55%)

33 (11.54%)

25 (8.62%)

 

oliguria

53 (24.31%)

77 (26.92%)

75 (25.86%)

 

others

57 (26.15%)

60 (20.98%)

67 (23.10%)

 

AKIN stage

   

0.983

stage II

59 (27.06%)

76 (26.57%)

79 (27.24%)

 

stage III

159 (72.94%)

210 (73.43%)

211 (72.76%)

 
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us